Takuya Matsunaga

• 造血細胞の in vitro 増幅
• 白血病細胞の抗癌剤耐性機序

• H Hamada, M Kobune, K Nakamura, Y Kawano, K Kato, O Honmou, K Houkin, T Matsunaga, YN Niitsu. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. CANCER SCIENCE. 2005. 96. 3. 149-156
• Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition. Int J Hematol. 2005. 81. 1. 18-25
• Human mesenchymal stem cells xenografted directly to rat liver differentiated into human hepatocytes without fusion. Blood. 2005. 7. 0-0
• Augmentation of Antitumor Effects of p53 Gene Therapy by Combination with HDAC Inhibitor. Cancer Biol Ther. 2005. 4. 0-0
• T Sato, T Matsunaga, M Kida, K Morii, T Machida, Y Kawano, K Nakamura, K Kuribayashi, K Takada, S Iyama, et al. Interleukin-11 as an osteoprotegerin-inducing factor in culture medium of blastic cells from a patient with acute megakaryocytic leukemia complicated with osteosclerosis. AMERICAN JOURNAL OF HEMATOLOGY. 2004. 77. 1. 62-66

ｍore...

• - 1988 Sapporo Medical University
• - 1988 Sapporo Medical University

• Ph D

• Kagawa University Faculty of Medicine Professor

• 2002 - 内科学会奨励賞
• 2002 - New Investigator Award, Japanese Society for Internal Medicine
• 2001 - 国際実験血液学会奨励賞
• 2001 - Young Investigator Award, International Society of Experimental Hematology

日本癌治療学会 ,  国際実験血液学会 ,  米国血液学会 ,  日本造血細胞移植学会 ,  日本臨床腫瘍学会 ,  日本内科学会 ,  日本癌学会 ,  日本臨床血液学会 ,  日本血液学会 ,  Intenational society of experimental hematology ,  American society of hematology ,  Japanese society of hematopoietic stem cell transplantation ,  Japanese society of clinical oncology ,  Japanese society of internal medicine ,  Japanese society of cancer research ,  Japanese society of clinical hematology ,  Japanese society of hematology